Comparison of a spectrophotometric microdilution method with RPMI-2% glucose with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro susceptibility testing of amphotericin B, flucytosine, and fluconazole against Candida albicans
- 1 September 1996
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 40 (9), 1998-2003
- https://doi.org/10.1128/aac.40.9.1998
Abstract
The National Committee for Clinical Laboratory Standards has proposed a reference broth macrodilution method for in vitro antifungal susceptibility testing of yeasts (the M27-P method). This method is cumbersome and time-consuming and includes MIC endpoint determination by visual and subjective inspection of growth inhibition after 48 h of incubation. An alternative microdilution procedure was compared with the M27-P method for determination of the amphotericin B, flucytosine, and fluconazole susceptibilities of 8 American Type Culture Collection strains (6 of them were quality control or reference strains) and 50 clinical isolates of candida albicans. This microdilution method uses as culture medium RPMI 1640 supplemented with 18 g of glucose per liter (RPMI-2% glucose). Preparation of drugs, basal medium, and inocula was done by following the recommendations of the National Committee for Clinical Laboratory Standards. The MIC endpoint was calculated objectively from the turbidimetric data read at 24 h. Increased growth of C. albicans in RPMI-2% glucose and its spectrophotometric reading allowed for the rapid (24 h) and objective calculation of MIC endpoints compared with previous microdilution methods with standard RPMI 1640. Nevertheless, good agreement was shown between the M27-P method and this microdilution test. The MICs obtained for the quality control or reference strains by the microdilution method were in the ranges published for those strains. For clinical isolates, the percentages of agreement were 100% for amphotericin B and fluconazole and 98.1% for flucytosine. These data suggest that this microdilution method may serve as a less subjective and more rapid alternative to the M27-P method for antifungal susceptibility testing of yeasts.Keywords
This publication has 14 references indexed in Scilit:
- Patterns of in vitro activity of itraconazole and imidazole antifungal agents against Candida albicans with decreased susceptibility to fluconazole from SpainAntimicrobial Agents and Chemotherapy, 1995
- Correlation of in-vitro susceptibility test results with clinical response: a study of azole therapy in AIDS patientsJournal of Antimicrobial Chemotherapy, 1995
- Defining conditions for microbroth antifungal susceptibility tests: influence of RPMI and RPMI-2% glucose on the selection of endpoint criteriaJournal of Antimicrobial Chemotherapy, 1995
- Improved method of determining the susceptibility of Candida albicans to fluconazoleJournal of Antimicrobial Chemotherapy, 1995
- Improved medium for fluconazole susceptibility testing of Candida albicansAntimicrobial Agents and Chemotherapy, 1994
- Secular Trends in the Epidemiology of Nosocomial Fungal Infections in the United States, 1980-1990The Journal of Infectious Diseases, 1993
- Secular trends in nosocomial primary bloodstream infections in the United States, 1980–1989American Journal Of Medicine, 1991
- Fluconazole susceptibility testing of Candida albicans: microtiter method that is independent of inoculum size, temperature, and time of readingAntimicrobial Agents and Chemotherapy, 1991
- Emerging fungal pathogensEuropean Journal of Clinical Microbiology & Infectious Diseases, 1989
- Antimicrobial Susceptibility Testing of Yeasts: a Turbidimetric Technique Independent of Inoculum SizeAntimicrobial Agents and Chemotherapy, 1976